reboxetine


Also found in: Dictionary, Thesaurus, Wikipedia.

reboxetine

A selective NORADRENALINE REUPTAKE INHIBITOR antidepressant drug. A brand name is Edronax.
Mentioned in ?
References in periodicals archive ?
In the approval studies for the selective inhibitors of monoamine reabsorption (SSRI, venlafaxine, duloxetine, reboxetine), it was not noticed that therapeutic doses of these drugs have any effect on the QTc interval (18).
Chronic treatment with various antidepressants like tranylcypromine, reboxetine, fluoxetine, and haloperidol is reported to increase neurogenesis in early adulthood and experimental models of stress [157].
Her other medications included nifedipine, reboxetine, and escitalopram, but her adherence to these medications was variable.
For the past 12 years, he had been seen as an outpatient in a psychiatry clinic where medication trials included citalopram, fluoxetine, venlafaxine, reboxetine, phenelzine, tranylcypromine, mirtazapine, lamotrigine, perphenazine, and diazepam.
On the other hand, reboxetine reduced lesion-induced depressive behavior on the forced swimming test [79].
Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test.
The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits, biochemical changes, and hippocampal synaptic plasticity in an animal model of depression.
Triple antidepressant combination Study SSRI (escitalopram 10mg) + TCA (amitriptyline Restifo [15] 25mg) + NARI (reboxetine 2mg) TeCA (mianserin 20mg) + TCA (nortriptyline 75mg) + NARI (reboxetine 1mg) SNRI (venlafaxine 150mg) + NaSSA (mirtazapine 7.5mg) + NARI (reboxetine 1mg) MAOI (tranylcypromine 70mg) + TCA (nortriptyline Thomas et al.
Antidepressant drugs are classified as: i) selective recapture inhibitors of 5-HT (SSRIs: Fluoxetine, citalopram, etc.) or of NA (NSRIs: Desipramine, reboxetine); ii) of both mono-amines (tricyclic: Imipramine, nortriptyline); iii) MAO-A inhibitors (tranylcypromine, selegiline, etc.) Notwithstanding, one of the enigmas of pharmacologic treatment is its time gap with therapeutic action (4 to 6 weeks) In this regard, it is propound that antidepressant drugs induce molecular adaptations of greater latency and duration which are more closely related to their therapeutic action.
In this group, reboxetine (2 mg) showed the maximum price variation of 900%, while amoxapine (50 mg) showed the minimum price variation of 17.72%.
There have been some published case reports on treatment of HPPD, including the use of Reboxetine, which suggest it is beneficial in the treatment of the visual disturbances and depressive features associated with HPPD.